Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.
Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2
From Critical Care Explorations. The authors identify the most efficacious timing for tocilizumab administration in critically ill patients infected with severe acute respiratory syndrome coronavirus-2.
Petrak RM, Van Hise NW, Skorodin NC, et al.
Estimated Time: 12:49 min
Categories:
Crisis Management, Infection,
Content Type:
Articles,